127 related articles for article (PubMed ID: 8665065)
1. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group.
Chin DP; Osmond D; Page-Shafer K; Glassroth J; Rosen MJ; Reichman LB; Kvale PA; Wallace JM; Poole WK; Hopewell PC
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1982-4. PubMed ID: 8665065
[TBL] [Abstract][Full Text] [Related]
2. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
3. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
[TBL] [Abstract][Full Text] [Related]
4. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
[TBL] [Abstract][Full Text] [Related]
5. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
6. Selection of skin test antigens to evaluate PPD anergy.
Wright PW; Crutcher JE; Holiday DB
J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
[TBL] [Abstract][Full Text] [Related]
7. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
Huebner RE; Schein MF; Hall CA; Barnes SA
Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
[TBL] [Abstract][Full Text] [Related]
10. Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group.
Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):93-8. PubMed ID: 9893191
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study.
Mofenson LM; Rodriguez EM; Hershow R; Fox HE; Landesman S; Tuomala R; Diaz C; Daniels E; Brambilla D
Arch Intern Med; 1995 May; 155(10):1066-72. PubMed ID: 7748050
[TBL] [Abstract][Full Text] [Related]
12. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
[TBL] [Abstract][Full Text] [Related]
13. Anergy during pregnancy.
Jackson TD; Murtha AP
Am J Obstet Gynecol; 2001 May; 184(6):1090-2. PubMed ID: 11349166
[TBL] [Abstract][Full Text] [Related]
14. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
[TBL] [Abstract][Full Text] [Related]
15. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
Klein RS; Gourevitch MN; Teeter R; Schoenbaum EE
Int J Tuberc Lung Dis; 2001 Aug; 5(8):707-11. PubMed ID: 11495260
[TBL] [Abstract][Full Text] [Related]
16. Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.
Klein RS; Sobel J; Flanigan T; Smith D; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):238-44. PubMed ID: 10077171
[TBL] [Abstract][Full Text] [Related]
17. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.
Delgado JC; Tsai EY; Thim S; Baena A; Boussiotis VA; Reynes JM; Sath S; Grosjean P; Yunis EJ; Goldfeld AE
Proc Natl Acad Sci U S A; 2002 May; 99(11):7576-81. PubMed ID: 12032325
[TBL] [Abstract][Full Text] [Related]
19. Identification of human immunodeficiency virus-infected individuals by delayed type hypersensitivity skin testing.
Metersky ML; Yang P; Nielsen HS; Catanzaro A
Ann Clin Lab Sci; 1998; 28(5):272-9. PubMed ID: 9784827
[TBL] [Abstract][Full Text] [Related]
20. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
Raszka WV; Moriarty RA; Ottolini MG; Waecker NJ; Ascher DP; Cieslak TJ; Fischer GW; Robb ML
J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
